For the past few decades, platinum based cisplatin has been a compound of choice in the treatment of many cancers. It is especially effective at halting testicular cancer, with a success rate of more than 90%. However, the usefulness of cisplatin and other metal based cancer drugs has been limited due to their toxicity, their resistance to other drugs in a person’s system, and a lack of long term stability. A study by RMIT University in Melbourne, Australia has announced the engineering of four gold based, bioactive molecules for use in cancer treatment that have been reported to be up to 24 times more effective.
To learn more, see original article at: https://www.medicalnewstoday.com/articles/326406.php
